Down-regulation of HLA class i antigen-processing machinery components in esophageal squamous cell carcinomas: Association with disease progression

Scandinavian Journal of Gastroenterology

Volumn 44, Issue 8, 2009, Pages 960-969

  Liu, Qiao ^a   Hao, Chunyan ^b   Su, Peng ^b   Shi, Juanhong ^b  

^a CANCER HOSPITAL   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

Antigen processing machinery; Cytotoxic T lymphocytes; Esophageal squamous cell carcinoma; HLA class I; Immune surveillance

Indexed keywords

ANTIGEN PROCESSING MACHINERY; BETA 2 MICROGLOBULIN; CARRIER PROTEIN; FORMALDEHYDE; HLA ANTIGEN CLASS 1; LATENT MEMBRANE PROTEIN 2; LATENT MEMBRANE PROTEIN 7; MULTIPROTEIN COMPLEX; PARAFFIN; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; AGED; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CHINA; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DOWN REGULATION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; HISTOPATHOLOGY; HOSPITAL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSURVEILLANCE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR CELL;

CARCINOMA, SQUAMOUS CELL; CD8-POSITIVE T-LYMPHOCYTES; CHINA; DISEASE PROGRESSION; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; FEMALE; GENES, MHC CLASS I; HUMANS; MALE; MIDDLE AGED;

EID: 70350686895     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365520902998679     Document Type: Article

References (35)

1. Groothuis TA, Griekspoor AC, Neijssen JJ, Herberts CA, Neefjes JJ. MHC class I alleles and their exploration of the antigen-processing machinery. Immunol Rev 2005;/207:/ 60-76.
2. Dunn GP, Koebel CM, Schreiber RD. Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006;/6:/ 836-48.
3. Flutter B, Gao B. MHC class I antigen presentation: recently trimmed and well presented. Cell Mol Immunol 2004;/1:/ 22-30.
4. Dunn GP, Old LJ, Schreiber RD. The immunobiology of cancer immunosurveillance and immunoediting. Immunity 2004;/21:/137-48.
5. Paschen A, Arens N, Sucker A, Greulich-Bode KM, Fonsatti E, Gloghini A, et al. The coincidence of chromosome 15 aberrations and beta2-microglobulin gene mutations is causative for the total loss of human leukocyte antigen class I expression in melanoma. Clin Cancer Res 2006;/12:/ 3297-305.
6. Hicklin DJ, Dellaratta DV, Kishore R, Liang B, Kageshita T, Ferrone S. Beta2-microglobulin gene mutations in human melanoma cells: molecular characterization and implications for immune surveillance. Melanoma Res 1997;/7 Suppl 2:/ S67-74.
7. Cresswell AC, Sisley K, Laws D, Parsons MA, Rennie IG, Murray AK. Reduced expression of TAP-1 and TAP-2 in posterior uveal melanoma is associated with progression to metastatic disease. Melanoma Res 2001;/11:/275-81.
8. Lou Y, Vitalis TZ, Basha G, Cai B, Chen SS, Choi KB, et al. Restoration of the expression of transporters associated with antigen processing in lung carcinoma increases tumorspecific immune responses and survival. Cancer Res 2005;/ 65:/7926-33.
9. Atkins D, Breuckmann A, Schmahl GE, Binner P, Ferrone S, Krummenauer F, et al. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma. Int J Cancer 2004;/109:/265-73.
10. Nie Y, Yang G, Song Y, Zhao X, So C, Liao J, et al. DNA hypermethylation is a mechanism for loss of expression of the HLA class I genes in human esophageal squamous cell carcinomas. Carcinogenesis 2001;/22:/1615-23.
11. Meissner M, Reichert TE, Kunkel M, Gooding W, Whiteside TL, Ferrone S, et al. Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome. Clin Cancer Res 2005;/11:/2552-60.
12. Vitale M, Rezzani R, Rodella L, Zauli G, Grigolato P, Cadei M, et al. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions. Cancer Res 1998;/58:/737-42.
13. Ramnath N, Tan D, Li Q, Hylander BL, Bogner P, Ryes L, et al. Is down-regulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?. Cancer Immunol Immunother 2006;/55:/ 891-9.
14. Seliger B, Atkins D, Bock M, Ritz U, Ferrone S, Huber C, et al. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation. Clin Cancer Res 2003;/ 9:/1721-7.
15. Han LY, Fletcher MS, Urbauer DL, Mueller P, Landen CN, Kamat AA, et al. HLA class I antigen processing machinery component expression and intratumoral T-cell infiltrate as independent prognostic markers in ovarian carcinoma. Clin Cancer Res 2008;/14:/3372-9.
16. Mehta AM, Jordanova ES, Kenter GG, Ferrone S, Fleuren GJ. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma. Cancer Immunol Immunother 2008;/57:/ 197-206.
17. Romero JM, Jimenez P, Cabrera T, Cozar JM, Pedrinaci S, Tallada M, et al. Coordinated downregulation of the antigen presentation machinery and HLA class I/beta2-microglobulin complex is responsible for HLA-ABC loss in bladder cancer. Int J Cancer 2005;/113:/605-10.
18. Zhang H, Melamed J, Wei P, Cox K, Frankel W, Bahnson RR, et al. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer. Cancer Immunol 2003;/3:/2.
19. Kageshita T, Hirai S, Ono T, Hicklin DJ, Ferrone S. Downregulation of HLA class I antigen-processing molecules in malignant melanoma: association with disease progression. Am J Pathol 1999;/154:/745-54.
20. Hosch SB, Izbicki JR, Pichlmeier U, Stoecklein N, Niendorf A, Knoefel WT, et al. Expression and prognostic significance of immunoregulatory molecules in esophageal cancer. Int J Cancer 1997;/74:/582-7.
21. Hosch SB, Meyer AJ, Schneider C, Stoecklein N, Prenzel KL, Pantel K, et al. Expression and prognostic significance of HLA class I, ICAM-1, and tumor-infiltrating lymphocytes in esophageal cancer. J Gastrointest Surg 1997;/1:/316-23.
22. Mizukami Y, Kono K, Maruyama T, Watanabe M, Kawaguchi Y, Kamimura K, et al. Downregulation of HLA class I molecules in the tumour is associated with a poor prognosis in patients with oesophageal squamous cell carcinoma. Br J Cancer 2008;/99:/1462-7.
23. Rockett JC, Darnton SJ, Crocker J, Matthews HR, Morris AG. Expression of HLA-ABC, HLA-DR and intercellular adhesion molecule-1 in oesophageal carcinoma. J Clin Pathol 1995;/48:/539-44.
24. Rockett JC, Darnton SJ, Crocker J, Matthews HR, Morris AG. Lymphocyte infiltration in oesophageal carcinoma: lack of correlation with MHC antigens, ICAM-1, and tumour stage and grade. J Clin Pathol 1996;/49:/264-7.
25. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for highthroughput molecular profiling of tumor specimens. Nat Med 1998;/4:/844-7.
26. Garrido F, Cabrera T, Accolla RS, Ferrone S, Fisch P. HLA and cancer: 12th International Histocompatibility Workshop Study. In: Charron D, editor. HLA genetic diversity of HLA, vol.1. Functional and medical implication. Paris: EDK; 1997. pp 445-52.
27. Zhang L, Conejo-Garcia JR, Katsaros D, Gimotty PA, Massobrio M, Regnani G, et al. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. N Engl J Med 2003;/348:/203-13.
28. Ogino T, Shigyo H, Ishii H, Katayama A, Miyokawa N, Harabuchi Y, et al. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 2006;/66:/9281-9.
29. Facoetti A, Nano R, Zelini P, Morbini P, Benericetti E, Ceroni M, et al. Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors. Clin Cancer Res 2005;/11:/8304-11.
30. Raffaghello L, Nozza P, Morandi F, Camoriano M, Wang X, Garre ML, et al. Expression and functional analysis of human leukocyte antigen class I antigen-processing machinery in medulloblastoma. Cancer Res 2007;/67:/5471-8.
31. Atkins D, Ferrone S, Schmahl GE, Storkel S, Seliger B. Down-regulation of HLA class I antigen processing molecules: an immune escape mechanism of renal cell carcinoma? J Urol 2004;/171:/885-9.
32. Kamarashev J, Ferrone S, Seifert B, Boni R, Nestle FO, Burg G, et al. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer 2001;/95:/23-8.
33. Tao J, Li Y, Liu YQ, Li L, Liu J, Shen X, et al. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors. Br J Dermatol 2008;/158:/ 88-94.
34. Hung CF, Cheng WF, He L, Ling M, Juang J, Lin CT, et al. Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes. Cancer Res 2003;/63:/2393-8.
35. Lou Y, Basha G, Seipp RP, Cai B, Chen SS, Moise AR, et al. Combining the antigen processing components TAP and Tapasin elicits enhanced tumor-free survival. Clin Cancer Res 2008;/14:/1494-501.